Omeros Corporation
OMER
$3.77
Share price
-3.18%
Change (1 day)
-30.25%
Change (1 year)
Categories
Omeros Corporation (OMER) - Cash on Hand
Cash on Hand as of March 2024 : $0.23 B
According to Omeros Corporation's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Omeros Corporation - Cash on Hand chart (from 2008 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.19 B | 23.94% |
| 2021-12-31 | $0.15 B | 16.53% |
| 2020-12-31 | $0.13 B | 122.01% |
| 2019-12-31 | $60.78 M | 0.48% |
| 2018-12-31 | $60.49 M | -27.76% |
| 2017-12-31 | $83.74 M | 84.75% |
| 2016-12-31 | $45.33 M | 60.39% |
| 2015-12-31 | $28.26 M | 310.44% |
| 2014-12-31 | $6.88 M | -51.17% |
| 2013-12-31 | $14.1 M | -36.91% |
| 2012-12-31 | $22.35 M | -9.04% |
| 2011-12-31 | $24.57 M | -41.49% |
| 2010-12-31 | $41.99 M | -30.37% |
| 2009-12-31 | $60.3 M | 201.8% |
| 2008-12-31 | $19.98 M | -17.03% |
| 2007-12-31 | $24.08 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $26.21 B | 11,282.60% | 🇺🇸 USA |
 Pfizer PFE | $11.92 B | 5,079.00% | 🇺🇸 USA |
 Genetic Technologies GENE | $2.54 M | -98.90% | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | $5.11 M | -97.78% | 🇺🇸 USA |